News - Page 235 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Mind Cure Announces its Research Program with Psychedelic Compounds

Mind Cure Announces its Research Program with Psychedelic Compounds

Post published:December 8, 2020
Post category:Press Release

Read more about the article New Wave: N2 Logics Launches New Website as They Explore Further Downstream Growth Opportunities

New Wave: N2 Logics Launches New Website as They Explore Further Downstream Growth Opportunities

Post published:December 7, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham

Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham

Post published:December 7, 2020
Post category:Press Release

Read more about the article CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth

Post published:December 7, 2020
Post category:Press Release

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

Post published:December 7, 2020
Post category:Press Release

Read more about the article Numinus Wellness Inc. Announces $10 Million Bought Deal Public Offering

Numinus Wellness Inc. Announces $10 Million Bought Deal Public Offering

Post published:December 7, 2020
Post category:Press Release

Read more about the article Psychedelics Research Review: November 2020

Psychedelics Research Review: November 2020

Post published:December 5, 2020
Post category:Psychedelics Research Review

Read more about the article Silo Pharma Comments on Recent Promotional and Trading Activities at Request of OTC Markets

Silo Pharma Comments on Recent Promotional and Trading Activities at Request of OTC Markets

Post published:December 4, 2020
Post category:Press Release

Read more about the article Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD

Psychedelic Bulletin: Numinus & MAPS Seek Approval for MDMA Trial in Canada; Psychedelic Companies Commission Research into Psilocybin, DMT, LSD

Post published:December 4, 2020
Post category:Psychedelic Bulletin

Read more about the article Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

Entheon Biomedical Announces Corporate Update Including Investment in Wonder Scientific

Post published:December 4, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.